BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15557605)

  • 1. Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis.
    Simmons WL; Denison AM; Dybvig K
    Infect Immun; 2004 Dec; 72(12):6846-51. PubMed ID: 15557605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.
    Simmons WL; Dybvig K
    Infect Immun; 2003 Oct; 71(10):5733-8. PubMed ID: 14500494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin.
    Simmons WL; Dybvig K
    Infect Immun; 2007 Aug; 75(8):3696-9. PubMed ID: 17517864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycoplasma polysaccharide protects against complement.
    Bolland JR; Simmons WL; Daubenspeck JM; Dybvig K
    Microbiology (Reading); 2012 Jul; 158(Pt 7):1867-1873. PubMed ID: 22504437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stochastic mechanism for biofilm formation by Mycoplasma pulmonis.
    Simmons WL; Bolland JR; Daubenspeck JM; Dybvig K
    J Bacteriol; 2007 Mar; 189(5):1905-13. PubMed ID: 17142389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Vsa shield of Mycoplasma pulmonis is antiphagocytic.
    Shaw BM; Simmons WL; Dybvig K
    Infect Immun; 2012 Feb; 80(2):704-9. PubMed ID: 22083715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycoplasma pulmonis Vsa proteins and polysaccharide modulate adherence to pulmonary epithelial cells.
    Bolland JR; Dybvig K
    FEMS Microbiol Lett; 2012 Jun; 331(1):25-30. PubMed ID: 22428866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene rearrangements in the vsa locus of Mycoplasma pulmonis.
    Shen X; Gumulak J; Yu H; French CT; Zou N; Dybvig K
    J Bacteriol; 2000 May; 182(10):2900-8. PubMed ID: 10781561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.
    Denison AM; Clapper B; Dybvig K
    Infect Immun; 2005 Apr; 73(4):2033-9. PubMed ID: 15784544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis.
    Shaw BM; Daubenspeck JM; Simmons WL; Dybvig K
    FEMS Microbiol Lett; 2013 Jan; 338(2):155-60. PubMed ID: 23190331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions.
    Bhugra B; Voelker LL; Zou N; Yu H; Dybvig K
    Mol Microbiol; 1995 Nov; 18(4):703-14. PubMed ID: 8817492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of viral and mycoplasmal infections, ammonia exposure, vitamin A deficiency, host age, and organism strain on adherence of Mycoplasma pulmonis in cultured rat tracheas.
    Schoeb TR; Juliana MM; Nichols PW; Davis JK; Lindsey JR
    Lab Anim Sci; 1993 Oct; 43(5):417-24. PubMed ID: 8277719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analysis of the chromosomal region around and within the V-1-encoding gene of Mycoplasma pulmonis: evidence for DNA inversion as a mechanism for V-1 variation.
    Simmons WL; Zuhua C; Glass JI; Simecka JW; Cassell GH; Watson HL
    Infect Immun; 1996 Feb; 64(2):472-9. PubMed ID: 8550194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the surface proteins and restriction enzyme systems of Mycoplasma pulmonis in the respiratory tract of infected rats.
    Gumulak-Smith J; Teachman A; Tu AH; Simecka JW; Lindsey JR; Dybvig K
    Mol Microbiol; 2001 May; 40(4):1037-44. PubMed ID: 11401710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of cationic antimicrobial peptides with Mycoplasma pulmonis.
    Park HJ; Kang KM; Dybvig K; Lee BL; Jung YW; Lee IH
    FEBS Lett; 2013 Oct; 587(20):3321-6. PubMed ID: 23994526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis.
    Fehri LF; Sirand-Pugnet P; Gourgues G; Jan G; Wróblewski H; Blanchard A
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4154-65. PubMed ID: 16189093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable number of tandem aminoacid repeats in adhesion-related CDS products in Mycoplasma hyopneumoniae strains.
    de Castro LA; Rodrigues Pedroso T; Kuchiishi SS; Ramenzoni M; Kich JD; Zaha A; Henning Vainstein M; Bunselmeyer Ferreira H
    Vet Microbiol; 2006 Sep; 116(4):258-69. PubMed ID: 16730926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of hydrogen peroxide production by Mycoplasma pulmonis to virulence for catalase-deficient mice.
    Brennan PC; Feinstein RN
    J Bacteriol; 1969 Jun; 98(3):1036-40. PubMed ID: 5788695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycoplasma pulmonis genital disease: effect of rat strain on pregnancy outcome.
    Reyes L; Steiner DA; Hutchison J; Crenshaw B; Brown MB
    Comp Med; 2000 Dec; 50(6):622-7. PubMed ID: 11200568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical diagnosis of mouse hepatitis virus and mycoplasma pulmonis infection with murine antiserum.
    Liang CT; Wu SC; Huang YT; Lin YC; Chang WJ; Chou JY; Liang SC; Liu CH
    J Comp Pathol; 2004; 131(2-3):214-20. PubMed ID: 15276861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.